Insights

Regenerative platform Xeltis is developing transformative implants that enable the natural creation of living and long-lasting vessels, with a focus on restoring tissue and reducing need for traditional grafts in vascular procedures. This suggests sales opportunities in hospitals pursuing advanced regenerative medicine and dialysis access solutions.

Axxess hemodialysis The aXess vascular implant for hemodialysis access is advancing toward FDA approval and US market launch, with recent European commercial activity and first patient treatment in Germany. Targeted outreach can be directed at nephrology networks, dialysis centers, and reimbursement stakeholders in the US and EU.

Strategic funding Recent funding rounds totaling over €20 million with backing from Horizon 3 Healthcare, Invest-NL and other strategic investors indicate strong investor confidence and potential for scaled manufacturing, clinical trials, and market entry, offering openings for partner agreements or co-development opportunities.

European expansion Commercial activity expanding in Europe and ongoing lab development at High Tech Campus Eindhoven signal readiness for regional partnerships, distribution agreements, and local regulatory navigation services to accelerate time-to-market in European healthcare systems.

Clinical and KOL engagement Active participation in global events (LSX World Congress) and a high-level medical leadership team (CMO involvement) point to opportunities for advisory boards, clinical collaborations, and projected case-based selling to vascular surgeons and nephrologists.

Similar companies to Xeltis

Xeltis Tech Stack

Xeltis uses 8 technology products and services including iCIMS, SOLIDWORKS, WordPress, and more. Explore Xeltis's tech stack below.

Media & News

Xeltis's Email Address Formats

Xeltis uses at least 4 email formats:
Xeltis Email FormatsExamplePercentage
First.Last@xeltis.comJohn.Doe@xeltis.com
90%
First.Middle.Last@xeltis.comJohn.Michael.Doe@xeltis.com
5%
FLast@xeltis.comJDoe@xeltis.com
3%
FMiddleLast@xeltis.comJMichaelDoe@xeltis.com
2%

Frequently Asked Questions

What is Xeltis's phone number?

Minus sign iconPlus sign icon
You can contact Xeltis's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Xeltis's official website and social media links?

Minus sign iconPlus sign icon
Xeltis's official website is xeltis.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Xeltis generate?

Minus sign iconPlus sign icon
As of October 2026, Xeltis's annual revenue is estimated to be $1M - $10M.

What is Xeltis's NAICS code?

Minus sign iconPlus sign icon
Xeltis's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Xeltis have currently?

Minus sign iconPlus sign icon
As of October 2026, Xeltis has approximately 81 employees across 2 continents, including Europe and North America. Key team members include Chief Executive Officer: E. S., Cfo: A. G. and Chief Operations Officer: L. V. O. Explore Xeltis's employee directory with LeadIQ.

What industry does Xeltis belong to?

Minus sign iconPlus sign icon
Xeltis operates in the Medical Equipment Manufacturing industry.

What technology does Xeltis use?

Minus sign iconPlus sign icon
Xeltis's tech stack includes iCIMS, SOLIDWORKS, WordPress, Shopify, Google Workspace, Google Cloud, Vimeo and Piwik PRO Core.

What is Xeltis's email format?

Minus sign iconPlus sign icon
Xeltis's email format typically follows the pattern of First.Last@xeltis.com. Find more Xeltis email formats with LeadIQ.

How much funding has Xeltis raised to date?

Minus sign iconPlus sign icon
As of October 2026, Xeltis has raised $253M in funding. The last funding round occurred on Dec 02, 2025 for $14M.

When was Xeltis founded?

Minus sign iconPlus sign icon
Xeltis was founded in 2006.
Xeltis logo

Xeltis

Medical Equipment ManufacturingNorth Brabant, Netherlands51-200 Employees

Xeltis is a medical equipment manufacturing company headquartered in Eindhoven, Netherlands, with a workforce of 51 to 200 employees. It develops artificial vessels and heart valves designed to be gradually replaced by the patient’s own living tissue. The company positions itself as a medtech scale-up with operations in Eindhoven and Zurich. In late 2025, Xeltis announced financing from the European Investment Bank and existing shareholders to support the advancement of its vascular access conduit to the market. More information is available on the company’s website at xeltis.com.

Section iconCompany Overview

Phone number
Website
xeltis.com
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2006
Employees
51-200

Section iconFunding & Financials

  • $253M

    Xeltis has raised a total of $253M of funding over 11 rounds. Their latest funding round was raised on Dec 02, 2025 in the amount of $14M as a Debt Financing.

  • $1M - $10M

    Xeltis's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.